Determination of in vitro synergy between linezolid and other antimicrobial agents against Mycobacterium tuberculosis isolates

Tuberculosis

Volumn 95, Issue 6, 2015, Pages 839-842

  Zou, Lin ^a,b   Liu, Min ^c   Wang, Yufeng ^b   Lu, Jie ^d   Pang, Yu ^a,b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Liaoning Provincial Center for Disease Control and Prevention   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Linezolid; Mycobacterium tuberculosis; Synergy

Indexed keywords

AMIKACIN; CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; TUBERCULOSTATIC AGENT;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; DRUG DETERMINATION; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; CHINA; COMBINATION DRUG THERAPY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTIBIOTICS, ANTITUBERCULAR; CHINA; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; LINEZOLID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84948715332     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.07.003     Document Type: Article

References (15)

1. World Health Oragnization Global tuberculosis report 2013 2014 World Health Organization Geneva, Switzerland
2. P. Glaziou, D. Falzon, K. Floyd, and M. Raviglione Global epidemiology of tuberculosis Semin Respir Crit Care Med 34 2013 3 16
3. Z. Zhang, T. Li, G. Qu, Y. Pang, and Y. Zhao In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates Int J Antimicrob Agents 45 2015 71 75
4. Y. Bhusal, C.M. Shiohira, and N. Yamane Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis Int J Antimicrob Agents 26 2005 292 297
5. S. De Lorenzo, J.W. Alffenaar, G. Sotgiu, R. Centis, L. D'Ambrosio, S. Tiberi, M.S. Bolhuis, R. van Altena, P. Viggiani, A. Piana, A. Spanevello, and G.B. Migliori Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB Eur Respir J 41 2013 1386 1392
6. Z. Zhang, Y. Pang, Y. Wang, C. Liu, and Y. Zhao Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China Int J Antimicrob Agents 43 2014 231 235
7. L. Zhang, Y. Pang, X. Yu, Y. Wang, M. Gao, H. Huang, and Y. Zhao Linezolid in the treatment of extensively drug-resistant tuberculosis Infection 42 2014 705 711
8. Y. Zhao, S. Xu, L. Wang, D.P. Chin, S. Wang, G. Jiang, H. Xia, Y. Zhou, Q. Li, X. Ou, Y. Pang, Y. Song, B. Zhao, H. Zhang, G. He, J. Guo, and Y. Wang National survey of drug-resistant tuberculosis in China N Engl J Med 366 2012 2161 2170
9. M.S. Bolhuis, T. van der Laan, J.G. Kosterink, T.S. van der Werf, D. van Soolingen, and J.W. Alffenaar In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis Eur Respir J 44 2014 808 811
10. J. van Ingen, M.J. Boeree, D. van Soolingen, and J.W. Mouton Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria Drug Resist Updat 15 2012 149 161
11. K.S. Long, and B. Vester Resistance to linezolid caused by modifications at its binding site on the ribosome Antimicrob Agents Chemother 56 2012 603 612
12. Z. Zhang, Y. Wang, Y. Pang, and K.M. Kam Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates J Clin Microbiol 52 2014 638 641
13. P.E. Almeida Da Silva, and J.C. Palomino Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs J Antimicrob Chemother 66 2011 1417 1430
14. A.A. Velayati, P. Farnia, T.A. Ibrahim, R.Z. Haroun, H.O. Kuan, J. Ghanavi, P. Farnia, A.N. Kabarei, P. Tabarsi, A.R. Omar, M. Varahram, and M.R. Masjedi Differences in cell wall thickness between resistant and nonresistant strains of Mycobacterium tuberculosis: using transmission electron microscopy Chemotherapy 55 2009 303 307
15. M.H. Hazbon, M. Bobadilla del Valle, M.I. Guerrero, M. Varma-Basil, I. Filliol, M. Cavatore, R. Colangeli, H. Safi, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. García-García, A. Davidow, M. Brimacombe, C.I. León, T. Porras, M. Bose, F. Chaves, K.D. Eisenach, J. Sifuentes-Osornio, A. Ponce de León, M.D. Cave, and D. Alland Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance Antimicrob Agents Chemother 49 2005 3794 3802